Cargando…
Hopes on immunotherapy targeting B7-H3 in neuroblastoma
Neuroblastoma is one of the most aggressive cancer forms in children, with highly heterogenous clinical manifestations ranging from spontaneous regression to high metastatic capacity. High-risk neuroblastoma has the highest mortality rates of all pediatric cancers, highlighting the urgent need for e...
Autores principales: | Pulido, Rafael, Nunes-Xavier, Caroline E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636568/ https://www.ncbi.nlm.nih.gov/pubmed/36327699 http://dx.doi.org/10.1016/j.tranon.2022.101580 |
Ejemplares similares
-
Immunotherapy of Neuroblastoma: Facts and Hopes
por: Anderson, John, et al.
Publicado: (2022) -
Editorial: Cell and Developmental Signalling in Neuroblastoma
por: Pulido, Rafael, et al.
Publicado: (2023) -
CLN7 gene therapy: hope for an ultra-rare condition
por: Brudvig, Jon J., et al.
Publicado: (2022) -
Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation
por: Nunes-Xavier, Caroline E., et al.
Publicado: (2019) -
Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets
por: Nunes-Xavier, Caroline E., et al.
Publicado: (2021)